UPT Perpustakaan Universitas Andalas
Repositori PerpustakaanUniversitas Andalas
 

Kajian Hubungan Titer Antibodi Anti-Sars-Cov-2 dengan Kipi dan Paparan Pasca Vaksinasi Covid-19 Astrazeneca di Sentral Vaksin Uta 45 Jakarta

dc.contributor.advisorYufri, Aldi
dc.contributor.advisorFatma, Sri Wahyuni
dc.contributor.advisorDiana, Layla
dc.contributor.authorLukas, Stefanus
dc.date.accessioned2026-09-24T22:22:20Z
dc.date.issued2024-07-25
dc.descriptionProf. Dr. apt. Yufri Aldi, M.Si.
dc.description.abstractPandemi yang disebabkan oleh virus corona baru, SARS-CoV-2, telah menjadi salah satu tantangan kesehatan terbesar yang dihadapi di seluruh dunia, dan lebih dari 700 ribu kematian hingga 6 Agustus 2020 di seluruh dunia. Pandemi Covid-19 ini telah berubah menjadi salah satu masalah kesehatan masyarakat. Dengan pemberian vaksin AstraZeneca ini diharapkan sistem imun dapat segera meningkat sehingga timbul antibodi selain itu terjadi efek samping dari vaksin disebut Kejadian Ikutan Pasca Imunisasi (KIPI). Penelitian ini bertujuan Mengkaji hubungan titer antibodi anti-SARS-CoV-2 dengan Paparan Covid-19 pasca vaksinasi AstraZeneca di Sentral Vaksin UTA 45 Jakarta Metode yang digunakan observasional retrospektif dan prospektif kohort.(n=102). Hasil penelitian ditemukan nilai rujukan antibodi 1 terdapat 36,3% reaktif, antibodi 2 terdapat 100% reaktif, pada saat antibodi 2 terjadi kenaikan rata-rata peserta vaksinasi sebesar 119 U/mL. Adanya hubungan antibodi 2 dengan sosiodemografi umur dan berolahraga, KIPI 1, 2 pada reaksi sistemik dan BMI (P value <0.05). Ditemukan pada KIPI 2 reaksi lokal yang tidak bergejala terjadi kenaikan 4/5 kali, reaksi sistemik 1/3 kali dan reaksi berat 1/50 kali, sedangkan pada bergejala tiga pada reaksi lokal terjadi penurunan 2 kali, reaksi sistemik1/2 kali, reaksi berat 0 (nol). Titer antibodi 2 ada hubungan dengan sosiodemografi komorbit, merokok dan minum alkohol (P value <0.05) sebagai peserta vaksin terpapar Covid-19. Peserta vaksinasi yang telah divaksinasi AstraZeneca dosis lengkap ada yang terpapar Covid-19 sebanyak 41 orang (40,2%) di rawat di rumah (isoman) 100%. Kesimpulan menemukan pemberian vaksinasi dosis lengkap AstraZeneca meningkatkan antibodi antiSARS-CoV-2 menjadi reaktif , secara kuantitatif meningkatkan titer antibodi anti SARS CoV-2 sebesar 119 U/mL, dan ada hubungan dengan KIPI reaksi sitemik.Pada KIPI 2 terjadi peningkatan pada yang tidak bergela, sedangkan pada yang bergejala terjadi penurunan. Pada peserta yang memiliki komorbiditas, kebiasaan merokok dan minum alkohol memudahkan terpapar Covid-19 tetapi ringan hanya di rawat di rumah (isoman).
dc.identifier.urihttps://ailib.my.id/handle/123456789/63049
dc.language.isoid
dc.publisherUniversitas Andalas
dc.subjectCovid-19
dc.subjectVaksin AstraZeneca
dc.subjectAntibodi
dc.subjectPaparan Covid -19
dc.subject.classificationR Medicine (General)
dc.titleKajian Hubungan Titer Antibodi Anti-Sars-Cov-2 dengan Kipi dan Paparan Pasca Vaksinasi Covid-19 Astrazeneca di Sentral Vaksin Uta 45 Jakarta
dc.typeThesis
dcterms.dateSubmitted2024-08-19
dcterms.referencesAbbas, A. K., Lichtman, A. H., & Pober, J. S. (2000). Cellular and molecular immunologi (4th Ed.). W.B Saunder Company. Ahmed, R., Lanier, J. G., & Pamer, E. (2002). Immunological memory and infection, dalam kaufman, E ., Sher, A. And Ahmed, R. Imunologi of infection disease. Washington D.C: Asm Press. Aisy, S. R., Rizal, A., & Simanjuntak, B. Y. (2023). Vitamin C, vitamin D dan imunitas pasien Covid-19. Journal Of Nutrition College, 12(1). Akib, A. A. P. & Takumansang, D. (2020). Alergi obat dalam buku ajar alergi imunologi anak, penyunting arwin. Jakarta: Balai Penerbit IDAI. Hal 73-76. Alemayehu, A., Demissie, A., Yusuf, M., Abdullahi, Y., Abdulwehab, R., Oljira, L., & Feleke, D. (2022). Covid-19 Vaccine Side Effect: Age And Gender Disparity In Adverse Effects Following The First Dose Of astrazeneca Covid-19 Vaccine Among The Vaccinated Population In Eastern Ethiopia: A Community-based study. SAGE Open Medicine, 10, 205031212211086. Https://Doi.Org/10.1177/20503121221108616 Almalki, O. S., Khalifa, A. S., Alhemeidi, O. F., Ewis, A. A., Shady, A. M., & Abdelwahab, S. F. (2022). Correlation Between The Severity Of Covid-19 Vaccine-Related Adverse Events And The Blood Group Of The Vaccinees In Saudi Arabia: A Web-Based Survey. Frontiers In Pharmacology, 13(November). Https://Doi.Org/10.3389/Fphar.2022.1006333 Alharbi NK, Et All., Persistence Of Anti-SARS-Cov-2 Spike Igg Antibodies Following Covid-19 vaccines. Infection and drug resistance. 2022;15(June):4127–36. DOI: 10.2147/IDR.S362848 Annisa, D. (2021). Situasi terkini perkembangan coronavirus disease (Covid-19) 16 November 2021. Infeksi Emgerging. Https://Infeksiemerging.Kemkes.Go.Id/Situasi-Infeksi-Emerging/Situasi-Terkini-Perkembangan-Coronavirus-Disease-Covid-19-16-November-2021 Badan Pusat Statistik. (N.D.). Mengulik data suku di indonesia. Badan Pusat Statistik. Badan Pusat Statistik. (2020). Jumlah penduduk hasil SP 2020 menurut wilayah dan jenis kelamin (Orang),2020. Badan Pusat Statistik. Badan Pusat Statistik. (2022a). Konsumsi alkohol oleh penduduk umur > 15 Tahun dalam satu tahun terakhir (Liter Perkapita) 2020-2022. Badan pusat statistik. Badan pusat statistik. (2022b). Persentase merokok pada penduduk umur >15 Tahun menurut provinsi (Persen) 2020-2022. Badan pusat statistik. BPOM. (2021). Fact sheet for health care providers emergency use authorization of (EUA) Of Coronavac. EUA-Coronavac Healt Care, BPOM ID EREG10040912100012. Burton Dennis (2023) Antiviral Neutralizing Antibodies: From In Vitro To In Vivo Activity, Https://Doi.Org/10.1038/S41577-023-00858-W Channappanavar, R., Fett, C., Mack, M., Ten Eyck, P. P., Meyerholz, D. K., & Perlman, S. (2017). Sex-Based Differences In Susceptibility To Severe Acute Respiratory Syndrome Coronavirus Infection. The Journal Of Immunology, 198(10), 4046–4053. Https://Doi.Org/10.4049/Jimmunol.1601896 Cheng, A., Hsieh, M. J., Chang, S. Y., Ieong, S. M., Cheng, C. Y., Sheng, W. H., & Chang, S. C. (2023). Correlation Of Adverse Effects And Antibody Responses Following Homologous And Heterologous Covid-19 Prime-Boost Vaccinations. Journal Of The Formosan Medical Association, 122(5), 384–392. Https://Doi.Org/10.1016/J.Jfma.2022.12.002 Choe, P. G., Kim, K. H., Kang, C. K., Suh, H. J., Kang, E. K., Lee, S. Y., Kim, N. J., Yi, J., Park, W. B., & Oh, M. D. (2021). Antibody Responses 8 Months After Asymptomatic Or Mild SARS-Cov-2 Infection. Emerging Infectious Diseases, 27(3), 928–931. Https://Doi.Org/10.3201/Eid2703.204543 Chowdhury, Sudipta Dhar, Oommen, Anu Mary (2020) Epidemiology Of Covid-19. Cobas (2021) Elecsys Anti-SARS-Cov-2 S, Https://Drive.Google.Com/File/D/1btvoqphh5bwfbti4ktks_El4ddrjfeec/View?Usp=Sharing Dai, M., Tao, L., Chen, Z., Tian, Z., Guo, X., Allen-Gipson, D. S., Tan, R., Li, R., Chai, L., Ai, F., & Liu, M. (2020). Influence Of Cigarettes And Alcohol On The Severity And Death Of Covid-19: A Multicenter Retrospective Study In Wuhan, Cina. Frontiers In Physiology, 11(December), 1–6. Https://Doi.Org/10.3389/Fphys.2020.588553 Dai XI-Jian, Et Al. (2022). Covid-19 Risk Appears To Vary Across Different Alcoholic Beverages. Frontiers. Depkes RI. (1995). Farmakope Indonesia Edisi IV. Departemen Kesehatan Republik Indonesia. Desalegn, M., Garoma, G., Tamrat, H., Desta, A., & Prakash, A. (2022). The Prevalence Of AstraZeneca Covid-19 Vaccine Side Effects Among Nigist Eleni Mohammed Memorial Comprehensive Specialized Hospital Health Workers. Cross Sectional Survey. Plos ONE, 17(6 June), 1–10. Https://Doi.Org/10.1371/Journal.Pone.0265140 Desnita, R., Sapardi, V. S., & Surya, D. O. (2022). Kejadian Ikutan Pasca Imunisasi (KIPI) Vaksin Covid-19 Dosis Pertama Dan Kedua. Jik Jurnal Ilmu Kesehatan, 6(1), 20. Https://Doi.Org/10.33757/Jik.V6i1.480 Dhamanti, I., Suwantika, A. A., Adlia, A., Yamani, L. N., & Yakub, F. (2023). Adverse Reactions Of Covid-19 Vaccines: A Scoping Review Of Observational Studies. International Journal Of General Medicine, 16(February), 609–618. Https://Doi.Org/10.2147/IJGM.S400458 Djalante, R., Lassa, J., Setiamarga, D., Sudjatma, A., Indrawan, M., Haryanto, B., Mahfud, C., Sinapoy, M. S., Djalante, S., Rafliana, I., Gunawan, L. A., Surtiari, G. A. K., & Warsilah, H. (2020). Review And Analysis Of Current Responses To Covid-19 In Indonesia: Period Of January To March 2020. Progress In Disaster Science, 6. Https://Doi.Org/10.1016/J.Pdisas.2020.100091 Dobaño, C., Ramírez-Morros, A., Alonso, S., Vidal-Alaball, J., Ruiz-Olalla, G., Vidal, M., Rubio, R., Cascant, E., Parras, D., Melero, N. R., Serra, P., Carolis, C., Santamaria, P., Forcada, A., Mendioroz, J., Aguilar, R., & Moncunill, G. (2021). Persistence And Baseline Determinants Of Seropositivity And Reinfection Rates In Health Care Workers Up To 12 . 5 Months After Covid -19. 1–6. Drożdżal, S., Rosik, J., Lechowicz, K., Machaj, F., Kotfis, K., Ghavami, S., & Łos, M. J. (2020a). FDA Approved Drugs With Pharmacotherapeutic Potential For SARS-Cov-2 (Covid-19) Therapy. Drug Resistance Updates, 53(July), 100719. Https://Doi.Org/10.1016/J.Drup.2020.100719 Earle, K. A., Ambrosino, D. M., Fiore-Gartland, A., Goldblatt, D., Gilbert, P. B., Siber, G. R., Dull, P., & Plotkin, S. A. (2021). Evidence For Antibody As A Protective Correlate For Covid-19 Vaccines. Vaccine, 39(32), 4423–4428. Https://Doi.Org/10.1016/J.Vaccine.2021.05.063 Ejaz, H. A, Abdullah Z, Izza J, Covid-19 And Comorbidities: Deleterious Impact On Infected Patients, Https://Pubmed.Ncbi.Nlm.Nih.Gov/32788073/ Fitero, Andreea B, Simona G, Omorbidities, Associated Diseases, And Riskassessment In Covid-19 - A Systematic Review, Https://Doi.Org/10.1155/2022/1571826 Fakultas Farmasi UGM, 2020, Perlunya Peningkatan System Imun Pada Pendemi Covid-19. Jogyakarta: Admin. Https://Farmasi.Ugm.Ac.Id/Id/Perlunya-Peningkatan -Sistem-Imun-Pada-Pendemi-Covid-19/ Eliakim N, Leibovici Yaara, Antibody Titers Before And After A Third Dose Of The SARS-Cov-2 BNT162b2 Vaccine In Adults Aged ≥60 Years, Https://Jamanetwork.Com/Journals/Jama/Fullarticle/2786096 Gaydos, J., Mcnally, A., Guo, R., William Vandivier, R., Simonian, P. L., & Burnham, E. L. (2016). Alcohol Abuse And Smoking Alter Inflammatory Mediator Production By Pulmonary And Systemic Immune Cells. American Journal Of Physiology - Lung Cellular And Molecular Physiology, 310(6), L507–L518. Https://Doi.Org/10.1152/Ajplung.00242.2015 Gudbjartsson, D. F., Norddahl, G. L., Melsted, P., Gunnarsdottir, K., Holm, H., Eythorsson, E., Arnthorsson, A. O., Helgason, D., Bjarnadottir, K., Ingvarsson, R. F., Thorsteinsdottir, B., Kristjansdottir, S., Birgisdottir, K., Kristinsdottir, A. M., Sigurdsson, M. I., Arnadottir, G. A., Ivarsdottir, E. V., Andresdottir, M., Jonsson, F., Stefansson, K. (2020). Humoral Immune Response To SARS-Cov-2 In Iceland. New England Journal Of Medicine, 383(18), 1724–1734. Https://Doi.Org/10.1056/Nejmoa2026116 Guo, Y., Cowman, K., Chang, M., Bao, H., Golia, A., Mcsweeney, T., Bard, L., Simpson, R., Andrews, E., Pirofski, L. Anne, & Nori, P. (2022). Assessment Of Unvaccinated And Vaccinated Patients With Coronavirus Disease 2019 (Covid -19) Treated With Monoclonal Antibodies During The Delta Wave (July 1–August 20, 2021): A Retrospective Observational Monocentric Study. BMC Infectious Diseases, 22(1), 1–8. Https://Doi.Org/10.1186/S12879-022-07626-6. Gurtman, A., Lockhart, S., Perez, J. L., Marc, G. P., Moreira, E. D., Zerbini, C., Bailey, R., Sc, B., Swanson, K. A., Ph, D., Roychoudhury, S., Ph, D., Koury, K., Ph, D., Li, P., Ph, D., Kalina, W. V, Ph, D., Cooper, D., … Group, T. (2020). New England Journal. 2603–2615. Https://Doi.Org/10.1056/Nejmoa2034577 Hassan, T., Saeed, S., Siddique, S., Babar, I., Sadaf, A., & Ayub, F. (2021). Comparison Between Covid-19 Vaccines Developed By Different Pharmaceuticals : A Short Review. RADS Journal Of Pharmacy And Pharmaceutical Sciences, 1–7. Hadi MI, M Yusuf Alamudi, Mirna Widiyanti. (2020). Teori Dan Konsep Dasar Imunologi. Malang: Intimedia Kelompok Intrans Publishing, Higgins,Victoria Fabros, Anselmokulasingam, Vathany (2021) Quantitative Measurement Of Anti-SARS-Cov-2 Antibodies DOI Https://Doi.Org/ 10.1055/S-0040-1712187. Hofmeyr, S. A. (2000). An Interpretative Introduction To The Immune System. Dept. Of Computer Science University Of New Mexico, 3, 3–26. Hu, B. D. (2021). Characteristics Of SARS-Cov-2 And Covid-19. Haddad, Chadia B.M , Sandrella S, Smoking And Covid-19: A Scoping Review, Https://Pubmed.Ncbi.Nlm.Nih.Gov/33642886/ Indarwati, R. (2020). Lindungi Lansia Dari Covid-19. Jurnal Keperawatan Komunitas, 5(1), 2020. Indonesia, K. Kesehatan Republik. (2021). Tanya Jawab. Kementerian Kesehatan RI. Iris Rengganis, PAPDI. (2021). Pembuatan vaksin uji laboratorium pada hewan/uji preklinik, uji klinik dan approval lissensi. Janssen Biotech. (2021). Emergency Use Authorization (EUA) Of The Janssen Covid -19 Vaccine To Prevent Coronavirus Disease 2019 (Covid-19). Sustainability (Switzerland), 11(1), 1–14. Jin, Y., Wang, M., Zuo, Z., Fan, C., Ye, F., Cai, Z., Wang, Y., Cui, H., Pan, K., & Xu, A. (2020). Diagnostic Value And Dynamic Variance Of Serum Antibody In Coronavirus Disease 2019. International Journal Of Infectious Diseases, 94, 49–52. Https://Doi.Org/10.1016/J.Ijid.2020.03.065 Kang, YM And Giraldo AA. (2014). Chapter 8: Eksperimental Autoimune Thyroiditis In The Mouse And Rat. 8: 123–145. Kementrian Kesehatan Republik Indonesia. (2020). Apa Yang Harus Dilakukan Masyarakat Untuk Cegah Penularan Covid-19. 2020, 1–24. Kementrian Kesehatan Republik Indonesia. (2020). Peraturan Menteri Kesehatan Republik Indonesia Nomor 8F4 Tahun 2020 Tentang Pelaksanaan Vaksinasi Dalam Rangka Penanggulangan Pandemi. 2019, 4. Kementrian Kesehatan Republik Indonesia, 2021. (2021). Keputusan Direktur Jenderal Pencegahan Dan Pengendalian Penyakit Nomor Hk.02.02/4/1/2021 Tentang Petunjuk Teknis Pelaksanaan Vaksinasi Dalam Rangka Penanggulangan Pandemi Corona Virus Disease 2019 (Covid-19). Kementerian Kesehatan RI, 4247608(021), 114. Kementrian Kesehatan Republik Indonesia. (2021). Vaksinasi Covid-19 Lindungi Diri, Lindungi Negeri. Kementerian Kesehatan RI, 9, 22–50. Kementerian Kesehatan Republik Indonesia. (2020). Question (Faq) Pelaksanaan Vaksinasi Covid-19. 2020, 1–16. Kementerian Kesehatan Republik Indonesia. (2021). Pelaksanaan Vaksinasi Covid-19 Di Indonesia Membutuhkan Waktu 15 Bulan. Sehat Negeriku, 2021. Kementrian Kesehatan Republik Indonesia. (2021). Masyarakat Indonesia Sambut Baik Vaksinasi Covid-19. Promkes.Kemkes.Go.Id, 2021. Kementrian Kesehatan Republik Indonesia. (2022). Paket Obat Covid-19 Yang Diberikan Secara GRATIS. Kementerian Kesehatan Republik Indonesia. Https://Faq.Kemkes.Go.Id/Faq/Paket-Obat-Covid-19-Yang-Diberikan-Secara-Gratis Kementrian Kesehatan Republik Indonesia. (2019). Keamanan Vaksin. 021, 5201590. Kementrian Kesehatan Republik Indonesia. (2021). Kelompok Komorbid Bisa Divaksinasi, Begini Ketentuannya. Kemkes.Go, 021, 1. Keminfo. (2020). Tahapan-tahapan pengembangan vaksin Covid-19 hingga produksi massal. Https://Www.Kominfo.Go.Id Kementrian Riset Dan Teknologi. (2020). Tahapan pembuatan vaksin. Kementrian Riset Dan Teknologi Badan Riset Dan Inovasi Nasional. Https://Bali.Kemenag.Go.Id/Jembrana/Berita/18014/Tahapan-Pembuatan-Vaksin Kewan, T., Flores, M., Mushtaq, K., Alwakeel, M., Burton, R., Campbell, J., Perry, H., Al-Jaghbeer, M., & Abi Fadel, F. (2021). Characteristics And Outcomes Of Adverse Events After Covid-19 Vaccination. JACEP Open, 2(5), 1–10. Https://Doi.Org/10.1002/Emp2.12565 Kim, Y., Liu, H., Galasiti Kankanamalage, A. C., Weerasekara, S., Hua, D. H., Groutas, W. C., Chang, K. O., & Pedersen, N. C. (2016). Reversal Of The Progression Of Fatal Coronavirus Infection In Cats By A Broad-Spectrum Coronavirus Protease Inhibitor. Plos Pathogens, 12(3), 1–18. Https://Doi.Org/10.1371/Journal.Ppat.1005531 Kimble, M. A., & Young, R.S. (2020). Pratinjau: patient compliance with medication issues and opportunities. Applied therapeutics :The Clinical Use Of Drugs (B. Alldredge, C. R. L, M. E. Ernst, G. B.Josepth, P. A. Jacobson, W. A Kradjan, & B. R. Williams, Eds.; Tenth Edit). Lippincott Williams&Wilkins.Awolter Kluwer Bussines, Philadelphia. Kleebayoon, A., & Wiwanitkit, V. (2023). Adverse effects and antibody responses following homologous and heterologous covid-19 prime-boost vaccinations. Journal of the formosan medical association, 122(5), 432–433. Https://Doi.Org/10.1016/J.Jfma.2022.12.018 Koesnoe, S. (2021). Teknis pelaksanaan vaksin covid-19 dan antisipasi kipi. Perhimpunan dokter spesialis penyakit dalam indonesia. Satgas imunisasi dewasa PB PAPDI. Kontopoulou, K., Nakas, C. T., & Papazisis, G. (2022). Significant Increase In Antibody Titers After The 3rd Booster Dose Of The Pfizer–Biontech Mrna Covid -19 Vaccine In Healthcare Workers In Greece. Vaccines, 10(6). Https://Doi.Org/10.3390/Vaccines10060876 Korishettar, G., Chikkahonnaiah, P., Tulimilli, S. R. V., Dallavalasa, S., Byrappa, S. H., Madhunapantula, S. R. V., & Veeranna, R. P. (2022). Assessment Of Clinical Profile And Treatment Outcome In Vaccinated And Unvaccinated SARS-Cov-2 Infected Patients. Vaccines, 10(7), 1–14. Https://Doi.Org/10.3390/Vaccines10071125 Kresno, B. S. (2010). Imunologi: diagnosis dan prosedur laboratorium, edisiv, Hal 26, 30, 36, badan penerbit fakultas kedokteran universitas indonesia, Jakarta. 2010. Kumar, S., Nyodu, R., Mauya, K. V., & Saxena, K. S. (2020). Morphology, Genome Organization, Replicatio, And Pathogenesis Of Servere Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2). In K. S. Saxena (Ed.), Springer Nature Singapore Pte Ltd (Vol. 3). Springer Nature Singapore Pte Ltd. Https://Doi.Org/10.1007/978-981-15-4814-7 Kusunoki, H., Ekawa, K., Ekawa, M., Kato, N., Yamasaki, K., Motone, M., & Shimizu, H. (2023). Trends In Antibody Titers After SARS-Cov-2 Vaccination—Insights From Self-Paid Tests At A General Internal Medicine Clinic. Medicines, 10(4), 27. Https://Doi.Org/10.3390/Medicines10040027 Khoury, D S Et Al (2021) neutralizing antibody levels are highly preductive of immune protection prom symptomatic SARS-Cov-2 Infection. Https://Www.Nature.Com/Articles/S41591-021-01377-8 Laing, K. (2020). Immune responces to viruses. In british society for immunology. Fred hutchinson canser research centre, Seattle, USA. Levy, I. (2022). Correlation between adverse events and antibody titer among healthcare workers vaccinated with BNT162b2 Mrna Covid-19 Vaccine. Vaccine, 10(8), 1220. Https://Doi.Org/10.3390/Vaccines10081220 Libretext (2022). Primary And Secondary Antibody Response. California: Nice Cxone Expert. Https://Bio.Libretexts.Org/@Go/Page/11791 Lopez Bernal, J., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., Stowe, J., Tessier, E., Groves, N., Dabrera, G., Myers, R., Campbell, C. N. J., Amirthalingam, G., Edmunds, M., Zambon, M., Brown, K. E., Hopkins, S., Chand, M., & Ramsay, M. (2021). Effectiveness of covid-19 vaccines against the b.1.617.2 (delta) variant. New england journal of medicine, 385(7), 585–594. Https://Doi.Org/10.1056/Nejmoa2108891 Louise, H. (2011). Buku saku imunologi berorientasi pada kasus klinik, binarupa aksara publisher, Tangerang Selatan. Lu, H., Stratton, C. W., & Tang, Y. W. (2020). Outbreak of pneumonia of unknown etiology in wuhan, cina: the mystery and the miracle. Journal of medical virology, 92(4), 401–402. Https://Doi.Org/10.1002/Jmv.25678 Maluneh AG Et All, 2022, More Than Three-Fourths Of AstraZeneca (Chadox1 COV-19) Covid-19 vaccinated individuals develop post immunization adverse event in northwest ethiopia. IDR. 2022 May;Volume 15:2409–16. Marliana, N., & Widhyasih, M. R. (2018). Imunoserologi (2018th Ed.). Kementrian Kesehatan Republik Indonesia. Pusat pendidikan sumber daya manusia kesehatan. Mioch, D., Vanbrabant, L., Reimerink, J., Kuiper, S., Lodder, E., Van Den Bijllaardt, W., Kluytmans, J., Wissing, M. D., Augustijn, H., Bartels, M., Van Jaarsveld, C. H. M., Leemans, M., Van Nierop, P., Van Riet, N., Raaijmakers, L., Reisiger, E., Reusken, C., Rietveld, A., & Salewicz, S. (2023). SARS-Cov-2 Antibodies Persist Up To 12 Months After Natural Infection In Healthy Employees Working In Non-Medical Contact-Intensive Professions. International Journal Of Infectious Diseases, 126, 155–163. Https://Doi.Org/10.1016/J.Ijid.2022.11.025 Moghadas, S. M., Vilches, N. T., Zhang, K., Wells, C. R., Shoukat, A., Singer, B. H., Meyers, A. L., Neuzil, M. K., Langley, J. M., Fitzpatrick, C. M., & Galvani, A. P. (2020). The Impact Of Vaccination On Covid-19 Outbreaks In The United State. National Institutes Of Healt, 192(19), E489–E496. Https://Doi.Org/10.1503/Cmaj.200457 Mona, N. (2020). Konsep isolasi dalam jaringan sosial untuk meminimalisasi efek contagious (kasus penyebaran virus corona di indonesia). Jurnal sosial humaniora terapan, 2(2). Https://Doi.Org/10.7454/Jsht.V2i2.86 Erniati, E., & Ezraneti, R. (2020). Aktivitas Imunomodulator Ekstrak Rumput Laut. Acta Aquatica: Aquatic Sciences Journal, 7(2), 79-86. Ollila, A. T., Lu, S., & Masel, R. (2021). Antibody Response To Covid-19 Vaccination In Adult With Hematologic Malignant Diasease. 932. Https://Doi.Org/10.1158/2159 Ossato, A., Tessari, R., Trabucchi, C., Zuppini, T., Realdon, N., & Marchesini, F. (2023). Comparison Of Medium-Term Adverse Reactions Induced By The First And Second Dose Of Mrna BNT162b2 (Comirnaty, Pfizer-Biontech) Vaccine: A Post-Marketing Italian Study Conducted Between 1 January And 28 February 2021. European Journal Of Hospital Pharmacy, 30(4), E15. Https://Doi.Org/10.1026/Ejhpharm-2021-002933 Oyebanji, O. A., Wilson, B., Keresztesy, D., Carias, L., Wilk, D., Payne, M., Aung, H., Denis, K. S., Lam, E. C., Rowley, C. F., Berry, S. D., Cameron, C. M., Cameron, M. J., Schmader, K. E., Balazs, A. B., King, C. L., Canaday, D. H., & Gravenstein, S. (2021). Does A Lack Of Vaccine Side Effects Correlate With Reduced BNT162b2 Mrna Vaccine Response Among Healthcare Workers And Nursing Home Residents? Aging Clinical And Experimental Research, 33(11), 3151–3160. Https://Doi.Org/10.1007/S40520-021-01987-9 Pallant, J., Suki., & Norazah, M. (2016). SPSS Survival Manual (4th Ed.). The Mcgraw-Hill Companies, Australia. Papagoras, C. (2021). Better outcomes of covid-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases. Annals of rheumatic disease, 81(7). Https://Doi.Org/Https://Doi.Org/10.1026/Annrheumdis-2021-221539 PAPDI. (2021, March 18). Rekomendasi papdi tentang pemberian vaksinasi covid-19 pada pasien dengan penyakit penyerta (Komorbit). PAPDI. Pemprov DKI Jakarta. (2020). Vaksinasi covid-19 dki jakarta apa itu vaksin vaksin covid-19 aman dan kenapa harus vaksin ? Vaksin diberikan hanya untuk mereka yang sehat efek samping vaksin covid-19. Corona.Jakarta.Go.Id, 2020. Raghottham Et All, 2019., registration requirement and approval procedure of vaccines in saudi arabia. Research journal of pharmacy and technology. 2019;12(9):4531–8. Rahmawati, & Putri, P. M. I. E. (2020). Learning from home dalam perspektif persepsi mahasiswa era pandemi Covid-19. Prosiding seminar nasional hardiknas, 1, 17–24. Ramalho, R., Adiukwu, F., Gashi Bytyçi, D., El Hayek, S., Gonzalez-Diaz, J. M., Larnaout, A., Orsolini, L., Pereira-Sanchez, V., Pinto Da Costa, M., Ransing, R., Shalbafan, M., Syarif, Z., & Grandinetti, P. (2021). Alcohol And Tobacco Use During The Covid-19 Pandemic. A Call For Local Actions For Global Impact. Frontiers In Psychiatry, 12(February), 10–13. Https://Doi.Org/10.3389/Fpsyt.2021.634254 Ramatillah, D. L., & Isnaini, S. (2021). Treatment profiles and clinical outcomes of covid-19 patients at private hospital In Jakarta. Plos ONE, 16(4 April), 1–11. Https://Doi.Org/10.1371/Journal.Pone.0250147 Ratcliffe, R. (2020, March). First coronavirus cases confirmed in indonesia amid fears nation Is Ill-Prepared For Outbreak | Indonesia | The Guardian. Roitt, I. M., Delves, P. J., Martin, S. J., Burton, D. R., Rondinone, S. N., & Tzal, K. (2017). Chapter 11: Adversarial Strategies During Infection Dalam Roitt’s Essential Immunology (13th Ed.). Wiley Blackwell. Saadah, L., Afrianti, E., Krisdianto,B,F.(2023), Lansia Dam Covid-19. Indramayu : Adab Jawa Barat. Https://Www.Google.Co.Id/Books/Edition/Lansia_Dan_Covid_19/5bfweaaaqbajHl=Id&Gbpv=1&Kptab=Getbook Salkiah, B. (2020). Perubahan paradigma pendidikan dan ekonomi dimasa pandemi Covid-19. Bina Ilmiah, 15(1), 3781. Sari, I. P., & Sriwidodo, S. (2020). Perkembangan teknologi terkini dalam mempercepat produksi vaksin Covid-19. Majalah Farmasetika, 5(5), 204. Https://Doi.Org/10.24198/Mfarmasetika.V5i5.28082 Satgas Covid-19. (2021). Pengendalian Covid-19. In Satuan Tugas Penanganan Covid-19 (Vol. 53, Issue 9). Salzberger, Bernd Buder, felix lampl, benedikt ehrenstein, boris hitzenbichler, florian (2021) epidemiology Of SARS-Cov-2. Publiser : Springer Berlin Heidelberg Https://Doi.Org/10.1007/S15010-020-01531-3 Science & Tech Spotlight. (2021). Covid-19 Vaccine Development. GAO. Gao.Gov/Product/Gao-20-583sp SK Bioscience. (2021). Fact sheet for health care providers emergency use authorization (EUA) Of Covid-19 Vaccine astrazeneca. Badan. 1–11. SK Saxena (2020). Coronavirus Disease (Covid-19)- Springer-Link https://link.springer.com. Syamaidzar, S. (2020). Review vaksin covid-19. Research gate, July, 1–15. Silkane V & Austers (2017) Exploring 35-44 Year Old Men’S Health Behaviour: A Qualitative Perspective. Tani N Et All, 2022,. Correlation of postvaccination fever with specific antibody response to severe acute respiratory syndrome coronavirus 2 bnt162b2 booster and no significant influence of antipyretic medication. Open forum infect dis. 2022 Sep 23;9(10):Ofac493. Tanriover Et All, 2021., efficacy and safety of an inactivated whole-virion sars-cov-2 vaccine (coronavac): Interim Results Of A Double-Blind, Randomised, Placebo-Controlled, Phase 3 Trial In Turkey. The Lancet. 2021;398(10296):213–22. Tjandra, Y. A. (2020). Covid-19 dalam tulisan prof. Tjandra. Lembaga penerbit badan penelitian dan pengembangan kesehatan (LPB). Tao Z Et All, 2021,. Anemia is associated with severe illness in covid-19: a retrospective cohort study. J Med Virol. 2021 Mar;93(3):1478–88. Todryk, S. M. (2018). T cell memory to vaccination. Vaccines, 6(4), 84. Https://Doi.Org/10.3390/Vaccines6040084 Utami, F. A., & Sani, F. (2021). Gambaran perilaku hidup bersih dan sehat (phbs) di era pandemi corona virus disease (covid-19) di indonesia. Jurnal biostatistik, kependudukan, dan informatika kesehatan, 1(3), 197–209. Usyal, E., Gumus, S., Bektore, B., Bozkurt, H., & Gozalan, A. (2021). Evaluation of antibody response after covid-19 vaccnation of healthcare workers. Journal of medical virology, 94(3). Https://Doi.Org/Https://Doi.Org/10.1002/Jmv.27420 Wang, F., Kream, R. M., & Stefano, G. B. (2020). An evidence based perspective on mrna-sarscov-2 vaccine development. Medical science monitor, 26, 1–8. Https://Doi.Org/10.12659/MSM.924700 Wei, J., Stoesser, N., Matthews, P. C., Ayoubkhani, D., Studley, R., Bell, I., Bell, J. I., Newton, J. N., Farrar, J., Diamond, I., Rourke, E., Howarth, A., Marsden, B. D., Hoosdally, S., Jones, E. Y., Stuart, D. I., Crook, D. W., Peto, T. E. A., Pouwels, K. B., Lee, J. (2021). Antibody responses to sars-cov-2 vaccines in 45,965 adults from the general population of the united kingdom. Nature microbiology, 6(9), 1140–1149. Https://Doi.Org/10.1038/S41564-021-00947-3 WHO. (2013). Vaccine Safety Basics. World Health Organization. WHO. (2021). Interim recommendations for use of the chadox1-s [recombinant] vaccine against Covid-19. World health organization, 19(January), 1–12. WHO. (2021). Introduksi keamanan vaksin, klasifikasi KIPI. 1–3. WHO. (2021). Update On Corona Virus Disease. WHO. Https://Www.Who.Int/Indonesia/News/Novel-Coronavirus WHO. (2021). Rekomendasi interim untuk penggunaan vaksin covid-19 inaktivasi, coronavac, yang dikembangkan oleh sinovac. Panduan interim, 1(4), 1–7. WHO. (2021). Background document on the inactivated vaccine sinovac-coronavac against Covid-19. World Health Organization. Yang, L., Liu, S., Liu, J., Zhang, Z., Wan, X., Huang, B., Chen, Y., & Zhang, Y. (2020). Covid-19: immunopathogenesis and immunotherapeutics. Signal transduction and targeted therapy, 5(1). Https://Doi.Org/10.1038/S41392-020-00243-2 Yunitasari, E., Putri, R. H., & Lestari, A. D. (2020). Wellness and healthy magazine. Wellness and healthy magazine, 2(February), 309–313. Zaher K, Et All 2023., differences in response to covid-19 infection and vaccination. Biomedicines. 2023 Jun 9;11(6):1677. Zhai, P., Ding, Y., Wu, X., Long, J., Zhong, Y., & Li, Y. (2020). The epidemiology, diagnosis and treatment of covid-19. International journal of antimicrobial agents, 55(5). Https://Doi.Org/10.1016/J.Ijantimicag.2020.105955 Zulkarnain, B. S., Kundiman, E. M. S., Aina, L., Ardianto, N., Meiliani, F., Rachman, M. P. A., Satryo, F. Z. O., Hapsari, P. P., Puspitasari, A. D., Rosyid, A. N., & Budiarti, T. Nur. (2022). Evaluation of covid-19 vaccine effectiveness among healthcare workers using cascade analysis. Jurnal kesehatan, 15(2), 92–97. Https://Doi.Org/10.24252/ Kesehatan.V15i2.27553 Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K. Y. (2016). Coronaviruses-drug discovery and therapeutic options. Nature reviews drug discovery, 15(5), 327–347. Https://Doi.Org/10.1038/Nrd.2015.37
local.eprints.dirdisk0/00/47/50/66
local.eprints.division10
local.eprints.id475066
local.eprints.typethesis/3Magister
local.eprints.urihttp://scholar.unand.ac.id/475066/
local.fakultasFakultas Farmasi
local.identifier.nim2131012003
local.thesis.levelTesis

Files

Collections